CSBTF Stock Price, Chart, Stats & News

Kuros Biosciences AG
Save
Kuros Biosciences AG (CSBTF) does not currently pay a dividend.
946.55M
Market cap
104.35x
Current P/E
–
Forward P/E
CSBTF chart
About
Health care
Sector
Biotechnology
Industry
Kuros Biosciences AG, a biopharmaceutical firm headquartered in Schlieren, Switzerland, specializes in both bringing to market and advancing therapeutic solutions for tissue repair and bone regeneration. Its global reach extends across the United States, the European Union, and other international markets, with operations strategically divided into Medical Devices, Pharmaceuticals, and a Legacy Portfolio. The company's innovative product lineup includes several key orthobiologics.
Similar securities
Based on sector and market capitalization
Report issue





